Global Tenders Banner Image

Most trusted source for Tendering Opportunities and Business Intelligence since 2002

Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Telmisartan + Amlodipine, Atc C09db04 For The Period 03/01/2023 - 02/28/2025

Germany has Released a tender for Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Telmisartan + Amlodipine, Atc C09db04 For The Period 03/01/2023 - 02/28/2025 in Pharmaceuticals. The tender was released on Jan 21, 2023. The GT reference number for the notice is 483519323. The scope of work comes under Medical solutions

Country - Germany

Summary - Conclusion Of A Non-exclusive Discount Agreement According To § 130a Para. 8 Sgb V On The Active Ingredient Telmisartan + Amlodipine, Atc C09db04 For The Period 03/01/2023 - 02/28/2025

Deadline - Jan 05, 2025

Authority Name - login to view

Product classification - Medical solutions

Organization Details:

  Address - Germany

  Contact details - 565656565

  Tender notice no. - 76454545

  GT Ref Id - 483519323

  Document Type - Tender Notices

Notice Details:

  Description - Contract notice: Conclusion of a non-exclusive discount agreement according to § 130a para. 8 sgb v on the active ingredient telmisartan + amlodipine, atc c09db04 for the period 03/01/2023 - 02/28/20 25 § 130a paragraph 8 sgb v enables the health insurance companies and pharmaceutical companies to conclude framework discount agreements for the drugs to be dispensed at the expense of the statutory health insurance companies. With regard to the relevant legal regulations for the award of public contracts, a regular process of active substance-related, formal award procedures takes place accord

Gt Ref Id - 483519323

Deadline - Jan 05, 2025

Documents :

  Soft Copy - View

Create Account

Why Us

2,00,000 +

Users

190 +

Countries Covered

1,00,000 +

Agencies Tracked

25,000 +

Notices Daily

50 Million +

Database